Parker Waichman Alonso LLP Supports FDA Proposal to Reclassify Transvaginal Mesh Products for Pelvic

Parker Waichman Alonso LLP, A National Law Firm, Supports FDA Proposal to Reclassify Transvaginal Mesh Products as High-Risk Medical Devices and Require Clinical Trials Prior to Approval as a Treatment for Pelvic Organ Prolapse. New York, New York (PRWEB) September 14, 2011 Parker Waichman Alonso LLP commends the U.S. Food & Drug Administration’s (FDA) proposal that transvaginal mesh devices used in the surgical repair of pelvic organ prolapse (POP) be reclassified as Class III medical devices, the agency's highest-risk category. This reclassification would make transvaginal mesh de
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories